Title : Combination Enoxaparin and Abciximab During Percutaneous Coronary Intervention: A New Standard of Care?

Pub. Date : 2000 May

PMID : 11096663






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Similarly, the low molecular weight heparin (LMWH), enoxaparin, has demonstrated superior efficacy when compared with unfractionated heparin (UFH) in the treatment of patients with non-ST elevation ACS. Enoxaparin 1-aminocyclopropane-1-carboxylate synthase homolog (inactive) Homo sapiens
2 Algorithms for seamless integration of pharmacotherpy through the course of hospitalization for patients who present with ACS and who require PCI will likely combine therapy with enoxaparin and platelet GP IIb/IIIa blockade (abciximab). Enoxaparin 1-aminocyclopropane-1-carboxylate synthase homolog (inactive) Homo sapiens